Skip to main content
Neurology logoLink to Neurology
. 2015 Dec 8;85(23):2084. doi: 10.1212/WNL.0000000000002206

Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial

PMCID: PMC5028322  PMID: 26644054

In the article “Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial” by J. Butchart et al. (Neurology® 2015;84:2161–2168), there is an error in the unit of measure used to report the CRP levels. They should have been reported as µg/mL rather than mg/mL. The authors regret the error.


Articles from Neurology are provided here courtesy of American Academy of Neurology

RESOURCES